These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 959284)

  • 41. [The homogeneity of suspension salves; tentative methods].
    SANDELL E
    Sven Farm Tidskr; 1952 Mar; 56(7):152-3. PubMed ID: 14942670
    [No Abstract]   [Full Text] [Related]  

  • 42. [Influence of viscosity on drug release from ointments, creams, gels and emulsions].
    Erös I; Soósné-Csányi E; Selmeczi B
    Acta Pharm Hung; 1994 Mar; 64(2):57-61. PubMed ID: 8017209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The influence of instrumental factors including membrane parameters on the drug liberation from ointments].
    Richter B; Kary J; Voigt R
    Pharmazie; 1975 Sep; 30(9):591-7. PubMed ID: 1187740
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.
    Dyderski S; Grześkowiak E; Szałek E; Mrzygłód A
    Acta Pol Pharm; 2001; 58(6):435-8. PubMed ID: 12197615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Viscosity of pharmacopeial multimolecular ointment vehicles and pharmaceutical availability of a model therapeutic agent.
    Piechota-Urbańska M; Kołodziejska J; Zgoda MM
    Polim Med; 2007; 37(2):3-19. PubMed ID: 17957945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physical and microbiological stability of an extemporaneous tacrolimus suspension for paediatric use.
    Han J; Beeton A; Long PF; Wong I; Tuleu C
    J Clin Pharm Ther; 2006 Apr; 31(2):167-72. PubMed ID: 16635051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reproducibility of observed dispersity decrease in boric acid suspension ointments].
    Horsch W; Kögel J
    Pharmazie; 1970 Jul; 25(7):434-5. PubMed ID: 5455436
    [No Abstract]   [Full Text] [Related]  

  • 50. [The dynamics of the drug release from ointment bases. Part 5: The effects of tensides on the liberation of atropine from eye ointments (author's transl)].
    Pasich J; Bether W; Malaga M
    Pharmazie; 1981 Apr; 36(4):267-9. PubMed ID: 7255527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [STUDIES ON THE QUALITATIVE CHARACTERISTICS OF GALENICALS AND DRUGS. 12. ESTIMATION OF TRITURATION GRADES OF SUSPENSION OINTMENTS BY A GRINDOMETER].
    MELICHAR M
    Pharmazie; 1963 May; 18():358-61. PubMed ID: 14061153
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of benzoic acid and salicylic acid in commercial benzoic and salicylic acids ointments by spectrophotometric method.
    Ahmad I; Vaid FH
    Pak J Pharm Sci; 2009 Jan; 22(1):18-22. PubMed ID: 19168414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Testing of methods for the determination of in vitro drug liberation in suppositories].
    Pflegel P; Sivako N; Elze H
    Pharmazie; 1986 Feb; 41(2):152-3. PubMed ID: 3725858
    [No Abstract]   [Full Text] [Related]  

  • 54. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the determination of the degree of dispersion in suspension ointments using the granulometer TuR ZG 2].
    Voigt R; Florstedt H; Bornschein M
    Pharmazie; 1973 Jan; 28(1):67-8. PubMed ID: 4714248
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on particle size problems. IV. Particle size stabilities during storage of suspensions of hydrocortisone acetate and prednisolone.
    Moller N; Jensen VG
    Dan Tidsskr Farm; 1970; 44(5):79-91. PubMed ID: 5518819
    [No Abstract]   [Full Text] [Related]  

  • 58. [Determination of the availability of insoluble medicinal substances in ointment-suspensions].
    Muraz'ev LA; Kononikhina NF
    Farmatsiia; 1977; 26(4):19-22. PubMed ID: 902787
    [No Abstract]   [Full Text] [Related]  

  • 59. [Modification of properties of hydrocarbon-ointments. 7. Effect of suspended substances on consistency].
    Hüttenrauch R; Süss W; Schmeiss U
    Pharmazie; 1974 Apr; 29(4):281-5. PubMed ID: 4368186
    [No Abstract]   [Full Text] [Related]  

  • 60. [Central preparation of suspension ointments].
    Naumann H
    Pharm Prax; 1971 May; 5():108-13. PubMed ID: 5562135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.